miR-548ag promotes DPP4 expression in hepatocytes through activation of TLR(7/8)/NF-κB pathway.
Jianyu XiongChaoyue SunXin WenYanting HouMaodi LiangJie LiuQianqian WeiFangyuan YuanChaoling PengYao ChenYongsheng ChangCuizhe WangJun ZhangPublished in: International journal of obesity (2005) (2024)
MiR-548ag promotes the expression of DPP4 in hepatocytes by activating the TLR(7/8)/NF-κB signalling pathway. MiR-548ag may be a potential target for the treatment of T2DM.